Ultralife Corporation
ULBI
$4.59
$0.010.22%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 43.85M | 35.69M | 42.98M | 41.93M | 44.55M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 43.85M | 35.69M | 42.98M | 41.93M | 44.55M |
| Cost of Revenue | 33.25M | 27.01M | 31.42M | 30.46M | 33.15M |
| Gross Profit | 10.60M | 8.68M | 11.56M | 11.47M | 11.40M |
| SG&A Expenses | 6.96M | 5.82M | 5.65M | 5.65M | 5.90M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 42.63M | 34.93M | 39.07M | 37.86M | 40.90M |
| Operating Income | 1.22M | 761.00K | 3.92M | 4.06M | 3.65M |
| Income Before Tax | 495.00K | 353.00K | 3.85M | 3.61M | 3.11M |
| Income Tax Expenses | 262.00K | 74.00K | 853.00K | 703.00K | 263.00K |
| Earnings from Continuing Operations | 233.00K | 279.00K | 2.99M | 2.90M | 2.85M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -39.00K | -21.00K | -24.00K | -13.00K | 23.00K |
| Net Income | 194.00K | 258.00K | 2.97M | 2.89M | 2.87M |
| EBIT | 1.22M | 761.00K | 3.92M | 4.06M | 3.65M |
| EBITDA | 2.40M | 1.76M | 4.93M | 5.03M | 4.62M |
| EPS Basic | 0.01 | 0.02 | 0.18 | 0.18 | 0.18 |
| Normalized Basic EPS | 0.01 | 0.02 | 0.14 | 0.14 | 0.06 |
| EPS Diluted | 0.01 | 0.02 | 0.18 | 0.18 | 0.17 |
| Normalized Diluted EPS | 0.01 | 0.02 | 0.14 | 0.14 | 0.06 |
| Average Basic Shares Outstanding | 16.63M | 16.63M | 16.57M | 16.40M | 16.34M |
| Average Diluted Shares Outstanding | 16.76M | 16.87M | 16.83M | 16.52M | 16.48M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |